CALL 2016 IS CLOSED

EuroNanoMed II Joint Transnational Call for Proposals (2016) for

“European Innovative Research & Technological Development Projects in

Nanomedicine”

CALL ANNOUNCEMENT

The 7th Call for Proposals of the EuroNanomed initiative is launched

On November 26th 2015

The ERA-NET EuroNanoMed II launches a seventh Joint Call for Proposals to support transnational innovative research projects in Nanomedicine.

Electronic submission website

Research project consortia who intend to submit a transnational proposal should register from January 7th 2016, at https://www.pt-it.de/ptoutline/application/euronanomed2016, following the instructions provided on the site. Registration and electronic proposal submission must be completed before 11th February 2016 17:00:00 CET.

Contact details for the Joint Call Secretariat:

JCS is hosted by the French National Research (ANR)

Postal Address: 50 avenue Daumesnil, 75012 PARIS – France

Tel. +33(0)1 78 09 80 44

Call related documents:

Call_text

Proposal submission_form

Guidelines for applicants – NEW! (Please note that the guidelines for applicants have been update on page 22 – Norway information for applicants; and on page 25 – Romania information for applicants)

JTC 2016 Pre-eligibility check form for ITALIAN RESEARCHERS (Please note that the Pre-eligibility check form for MOH-IT has been updated and the maximal amount per project can now reach 0.3M€)

AIMs of the call

The aims of the call are:

• To support translational research proposals that combine innovative approaches (basic, clinical, industrial ) in the field of Nanomedicine and;
• To encourage and enable transnational collaboration between public and private research groups from academia (research teams from universities, higher education institutions, public research institutions) and clinical/public health research (research teams from hospital/ public health, healthcare settings and other healthcare organizations) or research teams from industrial enterprises (all size). The participation of SMEs is encouraged.

TOPICS of the call

Project proposals will address multidisciplinary and translational research. The project proposals must cover at least one of the following areas that are equal in relevance for this call:

• Regenerative medicine
• Diagnostics
• Targeted delivery systems

General conditions for application

A consortium applying to this call must include research group(s) from at least two out of the three following categories, if eligible according to relevant national/regional funding organisation’s regulations for research funding:

• academia (research teams working in universities, other higher education institutions or research institutes);
• clinical/public health research sector (research teams working in hospitals/public health and/or other health care settings and health organizations);
• enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) is encouraged.

Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed II funding organization respective of the country/region from which applicants have applied. The applications are therefore subjected to eligibility criteria of individual funding organizations. Please note that the national eligibility conditions have evolved since the last EuroNanoMed call. Applicants are therefore strongly advised to contact their national representative as soon as possible in order to confirm their eligibility with their respective funding organizations. Only transnational projects will be funded. Each proposal must involve a minimum of three research groups eligible for the funding organisations participating in the EuroNanoMed II 7th Joint Transnational Call. Moreover, these eligible research groups must come from at least three different countries and no more than two eligible research groups from the same country participating in the call will be accepted. Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding. However, the majority of research groups in a consortium and the coordinator must be eligible to be funded by EuroNanoMed II participating countries/regions. In any case, the maximum number of participants in a project consortium is seven.

Contact Point list

Call documents

CALL 2016 TEXT (PDF)

CALL 2016 GUIDELINES (PDF)

CALL 2016 PROPOSAL TEMPLATE (DOC)

Statistics

EuroNanoMed I & II call statistics

During the period 2009-2016, the ERA-NET EuroNanoMed I & II have successfully launched 7 joint calls for proposals.

These joint calls for proposals funded 61 transnational research projects on nanomedicine involving 319 partners from 20 countries/regions participating in the calls and 5 additional non-participating countries, with about € 53.1 million funding from the EuroNanoMed funding agencies and a further € 36.7 million funding from the research partners participating in the funded projects.

Country of origin of the applicants

Altogether, 1659 partners from 32 countries participated in these joint calls, in a total of 326 submitted projects. As presented in figure 1, the number of applicants per country has globally grown between 2009 and 2016, as well as the number of submitted proposals (from 24 to 68 respectively).

Figure 1: Number of applicants per country for the 7 joint calls for proposals.

*NPC (Non-Participating Country) refers to applicants from countries that did not participate in the joint transnational call.

Overview of the 7 joint calls

The table below summarizes the outcomes of the 7 joint calls for proposals:

Participation of research organizations in translational projects in Nanomedicine

As EuroNanoMed I & II joint calls for proposals aimed at funding translational research projects in Nanomedicine, each consortium had to include teams from at least 2 of the following categories: academia, clinic/public health, industry. The distribution between these three categories among consortia funded in the 7 joint calls is outlined in Figure 2. Noteworthy, 53% of the funded projects included partners from all three categories, indicating the high added value of these collaborations in nanomedicine translational research.

Figure 2: Type of research organizations funded through the 7 joint calls for proposals.

Scientific / technological areas covered by funded projects

The 7 joint calls for proposals were open to projects covering at least one of the three priority topics of the European Technology Platform Nanomedicine: Targeted delivery systems, Diagnostics, Regenerative medicine. The coverage of these three scientific areas among funded projects is presented in figure 3.

Figure 3: Distribution of scientific areas covered by funded projects in the 7 joint calls for proposals.

PRP MEMBERS